

HY-139920A · 50 mg
MedChemExpress · Cat: HY-139920A
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/oritinib-mesylate.html
Description
Oritinib SH-1028 mesylate is a selective, orally active, and pyrimidine-based irreversible inhibitor of EGFR with an IC50 of 18 nM. Oritinib SH-1028 mesylate exhibits potent activity against EGFR sensitive and resistant T790 M mutations. Oritinib SH-1028 mesylate significantly inhibits proliferation of tumor cells with EGFR sensitive and resistant mutation.







